Back to search

Peptide record

TPDB07487

Antibacterial Anticancer Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB07487
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 Peptipedia
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from AntiBP3 and Peptipedia, with an available 3D structural model.
Sequence
WLRRIKAWLRRIKA
Physicochemical Analysis
C88H148N30O15
NDCEQGHMFPSTYV
R
1866.34
12.88
6
0
8
+6
-0.56
-0.529
125.71
Mammalian: 2.8 hour Yeast: 3 min E.coli: 2 min
11000
589.39
0
Residue Composition
number
2
A
4
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
2
I
2
L
2
K
0
M
0
F
0
P
0
S
0
T
2
W
0
Y
0
V
Amino Acid Distribution
A: 2 R: 4 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 2 L: 2 K: 2 M: 0 F: 0 P: 0 S: 0 T: 0 W: 2 Y: 0 V: 0
Chemical Descriptors
14
C88H148N30O15
1866.34
12.88
+6
-0.56
-0.529
Evidence Records 5 records
Evidence 1 Activity

Activity

MIC
Antibacterial
2-4 µM

Target

Staphylococcus aureus MSSA or MRSA many strains

Source & Reference

NA

Other

active against S. aureus MSSA or MRSA many strains (MIC 2-4 uM) and S. epidermidis (MIC 2 uM). Also antibiofilms.
Evidence 2 Activity

Activity

MIC
Antibacterial
2 µM

Target

Staphylococcus epidermidis

Source & Reference

NA

Other

active against S. aureus MSSA or MRSA many strains (MIC 2-4 uM) and S. epidermidis (MIC 2 uM). Also antibiofilms.
Evidence 3 Activity

Activity

IC50
Toxicity
64 µM
Cytotoxic
IC50 | 64 | µM | target cell: Murine macrophage cells J774A.1

Target

Murine macrophage cells J774A.1

Source & Reference

NA
DBAASP
Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs. | PLoS One | 2014
Evidence 4 Activity

Activity

IC50
Toxicity
128 µM
Cytotoxic
IC50 | 128 | µM | target cell: Human keratinocytes HaCat

Target

Human keratinocytes HaCat

Source & Reference

NA
DBAASP
Antibacterial Activity of Novel Cationic Peptides against Clinical Isolates of Multi-Drug Resistant Staphylococcus pseudintermedius from Infected Dogs. | PLoS One | 2014
Evidence 5 Activity

Activity

50% Hemolysis
Toxicity
256 µM
Hemolytic Cytotoxic
50% Hemolysis | 256 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
A short D-enantiomeric antimicrobial peptide with potent immunomodulatory and antibiofilm activity against multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii. | Sci Rep | 2017